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Abstract
Background:  Several studies were pointed to oxidized LDL (ox-LDL) as one of the main
immunogenes which have important roles in primary lesions of atherosclerosis. In this study, by
immunization against ox-LDL with two different antigens in an animal model (rabbit) and
consideration of its effect on two different dietary regimens; we tried to clear relation between
immune system and atherosclerosis.
Methods: LDL was isolated from hypercholesterolemic rabbits plasma and oxidized with MDA or
Cu++. Rabbits were divided to three groups and immunized with MDA-LDL or Cu-LDL or
phosphate-buffer (PBS) as a control group. Immunization was repeated after 2, 4, 6, and 8 weeks
and concentration of antibodies against ox-LDL was measured in each stage. After immunization,
rabbits in each group were divided to two subgroups based on the dietary regimen (fed normal or
high cholesterol diet). At the beginning and the end of the study, biochemical factors were
measured. Also, fatty streaks in aorta and left and right coronary arteries evaluated.
Results: Immunization with Cu2+-LDL and MDA-LDL induced statistically significant antibodies
against ox-LDL. In hypercholesterolemic rabbits immunized with MDA-LDL the level of
cholesterol, LDL-cholesterol, triglyceride, fasting blood sugar and fatty streak lesions in aorta and
right coronary arteries were significantly decreased as compared with non-immunized high-
cholesterol group. Immunization with Cu2+-LDL in hypercholesterolemic rabbits significantly
decreased triglyceride, fasting blood sugar, cholesterol and CRP. No significant differences were
detected in the fatty streak lesions in this group as compared with non-immunized high-cholesterol
diet. In groups under normal diet immunized with MDA-LDL or Cu2+-LDL no significant effect on
biochemical factors and atherosclerotic lesions were observed.
Conclusion:  This study indicates that although the effect of produced antibodies in several
methods and different dietary regimens is different, immunization against ox-LDL is
antiatherogenic.
Background
In the recent studies, relation between immune system
and atherosclerosis has been investigated [1-3]. It is clear
that this system can be effective on severity of atheroscle-
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rosis through different immunogenic mechanisms [4-6].
Several studies were pointed to oxidized LDL (ox-LDL) as
one of the main immunogenes which have important
roles in primary lesions of atherosclerosis [5,6]. Little
changes in LDL strongly converted it to immunogenic par-
ticle. ox-LDL is a toxic particle that stimulates several cel-
lular and humeral responses [7]. The existence of activated
macrophages against ox-LDL in atherosclerotic lesions is a
marker for primary cellular responses [8]. Different types
of antibodies against ox-LDL were recognized in blood
stream. These antibodies are measured in both human
and animal models [9-12] bind to ox-LDL epitopes and
cause atherosclerosis. As, hypercholesterolemic rabbits
immunized with homologous, ox-LDL have a markedly
reduced neointimal area after balloon injury despite sever
hypercholesterolemia, then immunization against athero-
sclerosis also is a target to prevent restenosis and further
investigation in this field is warranted [13].
However, the atherogenic or athero-protective role of
immune system in atherosclerosis is not clearly demon-
strated. In this study, by immunization against ox-LDL
with two different antigens in an animal model (rabbit)
and consideration of its effect on two different dietary reg-
imens (fed normal or high cholesterol diet); we tried to
clear relation between immune system and atherosclero-
sis.
Methods
Isolation and oxidation of LDL
LDL was isolated by ultracentrifuge from healthy New
Zealand white rabbits with diet-induced hypercholestero-
lemia and modified with MDA and Cu2+. LDL (1.019 < d
< 1.063 g/mL) was isolated by sequential ultracentrifuga-
tion in the presence of antioxidants and antiproteolytic
agents. The density was adjusted to 1.022 g/mL with KBr,
then plasma was centrifuged at 65000 rpm for 4 hours at
10°C using a Beckman L7-65 ultracentrifuge with a VTi
65.2 rotor. The supernatant was pipetted off, the density
of the infranatant was adjusted to 1.063 g/mL with KBr,
and the LDL fraction was isolated by centrifugation at
44000 rpm for 22 hours using a 50.3 rotor. LDL was then
extensively dialyzed against EDTA-free phosphate buffer
(PBS) and sterile filtered [14].
Cu-LDL was generated by incubating 160 µg LDL per mL
PBS, pH 7.35, with 5 µmol/L CuSO4 at 37°C [14,15].
Oxidation of LDL by MDA is carried out according to
Foglemen procedure [16].
Immunization of rabbits
Thirty-six New Zealand white male rabbits with the mean
weight of 2000 ± 200 grams were prepared from Pasteur's
Institute. Animals were fed with normal diet (Super
Fosskorn) for two weeks and then were divided into three
groups of twelve rabbits each and matched for age, body
weight, and plasma cholesterol levels. Also, environmen-
tal characteristics (light, temperature, and assess to water)
were similar. The first (n = 12) group was immunized with
(160 µg/kg) homologous MDA-modified LDL (protein)
and dissolved in PBS and suspended in an equal volume
of Freund's adjuvant. The second group (n = 12) was
immunized with (160 µg/kg) homologous cu-LDL (pro-
tein) and dissolved in PBS and suspended in an equal vol-
ume of the same concentration of Freund's adjuvant. The
third group (n = 12) was immunized only with PBS (con-
trol group). Immunization was repeated with an identical
protocol, again after of 2, 4, 6 and 8 weeks.
Experimental animals and dietary regimens
At the end of immunization, each group of rabbits was
divided into two subgroups with 6 rabbits and each sub-
group was fed normal or high cholesterol diets (normal
rabbit diet supplemented with 1% cholesterol) for 2
months. Rabbits were kept on a 12 hour day/night cycle
and had unrestricted access to water and food ad libitum.
Biochemical Measurments
Blood samples were collected from central ear artery of
overnight fasted rabbits before starting experiments and at
the end of study. Plasma cholesterol, triglyceride, high
density cholesterol (HDL-C), low density choles-
terol(LDL-C), and fasting blood sugar levels were deter-
mined using an automated enzymatic assay by auto-
analyzer Hitachi 902 and using special kits (Diasys, Ger-
many). CRP levels were measured by rabbit CRP Eliza
Kit(Rapidbio, USA). ox-LDL antibodies measured with
Eliza method (Immunodiagnostica, Germany). Also,
external standardization for lipoproteins and fasting
blood sugar level was done with the central laboratory of
the St. Rafael University Hospital of Leuven in Belgium.
The results of two laboratories correlated highly.
Isfahan Cardiovascular Research Center Ethics Committee
which is a member of office for human research protec-
tions, US department of health and human services,
approved the present study, and the animals were han-
dled according to guidelines of Isfahan University of Med-
ical Sciences for Laboratory Animal Sciences for the care
and use of laboratory animals.
Evaluation of atherosclerosis
At the end of study, after anaesthetization of rabbits with
pentobarbital 5% and cut of chest each animal was sacri-
ficed and gross anatomic examinations and pathologic
investigations were performed on the subject. Then, the
right and the left coronary arteries as well as aorta were
excised and kept in 10% formalin solution to be used for
pathologic evaluation. Tissue specimens were sectioned
and prepared using particular histological methods andLipids in Health and Disease 2007, 6:32 http://www.lipidworld.com/content/6/1/32
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were assessed by a pathologist with respect to the presence
of fatty streaks. For every animal subject and from each tis-
sue specimens, either right coronary artery, left coronary
artery or aorta; three consecutive sections were prepared
and mounted on one slide. Prepared tissue sections were
observed using light microscope. They were all scored on
the basis of the scale from zero to four [17].
Statistical analysis
Results were presented as the mean ± SD. Differences in
means of biochemical factors and fatty streak scores
between groups were statistically analyzed by non-para-
metric one-way analysis of variance.
P values < 0.05 were considered statistically significant. A
computer program (SPSS 13.0, SPSS Inc. Chicago, IL,
USA) was used for statistical analysis.
Results
Antibody measurements after 4, 6 and 8 weeks, were sta-
tistically more in rabbits immunized with MDA-LDL and
Cu-LDL than PBS group (Fig 1).
Table 1 summarized the effect of immunization against
MDA-LDL and Cu-LDL on the rabbits fed normal diet or
high cholesterol diet on biochemical factors.
Immunization with MDA-LDL under high cholesterol diet
statistically decreased serum concentration of triglyceride,
cholesterol, fasting blood sugar, and LDL-C as compared
with non-immunized high-cholesterol group (Table 1).
Immunization with Cu-LDL under high cholesterol diet
statistically decreased serum concentration of triglyceride,
cholesterol, fasting blood sugar and CRP as compared
with non-immunized high cholesterol group (Table 1).
Also, it was a significant difference between the mean
changes of fatty streak measurement in aorta and right
coronary artery in group under high cholesterol diet
immunized with MDA-LDL as compared with non-
immunized high cholestrol group (Table 2). In the group
under high cholesterol diet immunized with Cu-LDL, the
mean of CRP was statistically lower than group under
high cholesterol diet immunized with MDA-LDL and also
hypercholesterolemic group. At the end of the study in
groups under normal diet immunized with MDA-LDL or
Cu-LDL, no significant difference in the mean of bio-
chemical factors or fatty streaks was observed (Table 1 and
Table 2).
Discussion
In the present study, significant decrease in fatty streak in
aorta and right coronary arteries in immunized rabbits
with MDA-LDL fed high cholesterol diet was observed
whereas in rabbits immunized with Cu-LDL fed high cho-
lesterol diet, no significant changes in fatty streaks was
found. In Palinski and Ameli studies (on rabbits fed with
high cholesterol diet through immunization with MDA-
LDL and Cu-LDL, respectively); it was found decrease of
atherosclerosis severity [18,19]. In the two distinct studies
of Palinski and Ameli different animal models, different
antigens, different modes of immunizations, and different
techniques for evaluation were used but in our study we
tried to evaluate the effects in the same study in addition
to use two different dietary regimen. Also, in this study,
decreasing of cholesterol, LDL-C, triglyceride and fasting
blood sugar in group immunized with MDA-LDL fed high
cholesterol diet in comparison with control group and
decrease of triglyceride, cholesterol, fasting blood sugar
and CRP in group immunized with Cu-LDL fed high cho-
lesterol diet in comparison with control group were
found. Therefore, these results can be an expression of dif-
ferences in the mechanism of these two antigens. In sev-
eral studies, it was found that CRP as a nonspecific marker
for diagnosis of cardiovascular disease can indirectly
influence on atherosclerosis [20]. It is suggested to study
the effect of immunization on different inflammatory
markers and its short and long term effect. Therefore,
selection of a suitable antigen can probably influence on
increasing of immunization effects on atherosclerosis.
Also, in our study, since immunization with MDA-LDL or
Cu-LDL did not influence biochemical factors and fatty
streaks in normal diet, atherogenic effect of immune sys-
tem not be proved. In present study, we also used Freund's
adjuvant. Administration of Freund's adjuvant alone can
reduce formation of mature atherosclerotic lesions in
experimental animal [21,22]. Therefore we can probably
ascribe a part of our study results to this adjuvant.
The mean of ox- LDL antibodies in rabbits immunized with  MDA-LDL, Cu-LDL, and only PBS in different times Figure 1
The mean of ox- LDL antibodies in rabbits immunized with 
MDA-LDL, Cu-LDL, and only PBS in different times. P < 0.05 
as compared with rabbits immunized with PBS(Control).L
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Table 1: Comparison of the mean of biochemical factors before and after immunization in immunized rabbits fed normal and high cholesterol diet
High cholesterol diet Normal diet
Cu-LDL MDA-LDL Control Cu-LDL MDA-LDL Control
After 
immunization
Before 
immunization
After 
immunization
Before 
immunization
After 
immunization
Before 
immunization
After 
immunization
Before 
immunization
After 
immunization
Before 
mmunization
After 
immunization
Before i
mmunization
Biochemical 
factor (mg/dl)
503 ± 136.8 18.7 ± 11 403.6 ± 218* 16.8 ± 5.3 558.7 ± 42.2 13.8 ± 8.7 26 ± 15.0 15.3 ± 12.7 21 ± 9.5 19.1 ± 5.7 17.4 ± 11.8 22.2 ± 15.3 LDL-C
128 ± 19.3 39.6 ± 14 114 ± 26.5 35.4 ± 4.9 103 ± 6.2 33.6 ± 1.5 36.7 ± 2.3 29.2 ± 4.9 36.5 ± 3.5 36.5 ± 2.6 30.0 ± 15.3 35.0 ± 8.4 HDL-C
1.2 ± 2.3** 0.8 ± 0.2 2.4 ± 0.3 0.8 ± .24 2.1 ± 0.69 0.9 ± 0.44 1.04 ± 0.5 0.7 ± 0.3 1.1 ± 0.4 0.9 ± 0.25 1.04 ± 0.36 1.04 ± 0.63 CRP
198.8 ± 49.2* 116 ± 20.8 136 ± 41* 105 ± 39.8 254.8 ± 139.4 116 ± 31.4 110 ± 29.6 125.7 ± 19.5 150 ± 10.8 136 ± 16.7 77.0 ± 16.2 63.3 ± 26.6 TG
62.3 ± 3.7* 81.6 ± 9.6 62.3 ± 4.8* 85.4 ± 8.3 82.6 ± 15.7 80.2 ± 39.8 83.7 ± 7.9 58.7 ± 9.9 82 ± 17 58.5 ± 9.9 80.8 ± 11.3 70.0 ± 12.8 FBS
671 ± 144.6* 63.7 ± 15.2 545.8 ± 276.7* 58.8 ± 7.4 711.2 ± 63.4 68.2 ± 15.3 73 ± 18.0 64.7 ± 20.7 93 ± 16.9 55.7 ± 5.3 63.0 ± 27.1 71.0 ± 24.0 CHOL
LDL-C: Low Density Lipoprotein, HDL-C: High Density Lipoprotein, CRP: C-Reactive Protein, TG: Triglyceride, FBS: Fasting Blood Sugar, CHOL: Cholesterol Measurements 
were expressed as Mean ± SD
* Statistically significant difference with non- immunized high-cholesterol diet (P < 0.05)
** Statistically significant difference with non-immunized high-cholesterol diet and also with high cholesterol diet immunized with MDA-LDL (P < 0.05)Lipids in Health and Disease 2007, 6:32 http://www.lipidworld.com/content/6/1/32
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Conclusion
In the present study, we concluded that immune response
to ox-LDL is anti atherogenic; Although, the effect of pro-
duced antibodies in various methods and dietary regi-
mens was different. Therefore, the hypothesis of the role
of protective effects of immune system on atherosclerosis
will be strongly debated. As the concept of immuno-
therapy is in its early stage of development so it should be
evaluated and therefore it is logical to study: when immu-
nization should be started which antigen is effective and
if dietary regimen or patient condition is effective in
decreasing atherosclerosis or not.
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